Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.93 | N/A |
| PEG Ratio (TTM) | 0.26 | N/A |
| P/S Ratio (TTM) | 0.50 | N/A |
| P/B Ratio (TTM) | 1.74 | N/A |
| P/FCF Ratio (TTM) | 22.39 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.10 | N/A |
| Price to 5YR AVG FCF Ratio | 11.78 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.22% | N/A |
| ROE (TTM) | 10.61% | N/A |
| Net Profit Margin (TTM) | 2.95% | N/A |
| ROIC 5YR AVG | 14.29% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 315.21% | -8.36% | -7.32% |
| Revenue | 1.01% | -6.49% | -3.53% |
| Net Income | 313.02% | -6.90% | -7.61% |
| Cash Flow | 379.57% | 22.04% | 115.35% |
Health (84%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.93 | N/A |
| Quick Ratio (TTM) | 2.85 | N/A |
| D/E Ratio (TTM) | 0.05 | N/A |
| Interest Coverage (TTM) | 11.03 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 4.96 | N/A |
| LTL to 5YR AVG FCF | 0.31 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.08% | N/A |